![](https://bigul.co/stock-screener/assetData/img/bar-shape.png)
![](https://bigul.co/stock-screener/assetData/img/pointer.png)
Bullish Moving Averages
4
Bearish Moving Averages
12
Back Stocks profile
Open Price
8.20Prev. Close
8.2000Volume
123000.00Value
1002450.00Market Cap Cr
19.60
Price to Earnings
0.00
Price to Book Value
0.50
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM Cr
0.00
Net Profit TTM Cr
0.00
Cash From Operating Activity Cr
-5.42
Return on Equity %
2.89
EMA & SMA
Bullish Moving Averages
4
Bearish Moving Averages
12
DELIVERY AND VOLUME
03 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
8.26
Second Resistance
8.36
Third Resistance
8.50
First Support
8.02
Second Support
7.88
Third Support
7.78
Relative Strength Index
45.74
Money Flow Index
45.71
MACD
-0.14
MACD Signal
-0.17
Average True Range
0.34
Average Directional Index
18.31
Rate of Change (21)
-3.09
Rate of Change (125)
-25.34
Commodity Channel Index
-30.1
Williams %R
-64
BETA
1 Month
0.76
3 Month
0.96
1 Year
0.96
3 Year
PRICE CHANGE ANALYSIS
1 Week
Low
High
7.92
8.33
1 Month
Low
High
7.51
8.8
3 Months
Low
High
7.51
11.15
6 Months
Low
High
7.51
17.38
1 Year
Low
High
7.51
29.35
Dipna Pharmachem Ltd - 543594 - Submission Of Audited Financial Results For The Half Year And Year Ended On 31St March, 2024 Along With Auditor'S Report
Submission of Audited Financial Result of the Half year and year ended on 31st March, 2024 along with Auditor''s ReportDipna Pharmachem Ltd - 543594 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On 12Th June, 2024
Pursuant to Regulations 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., on 12th June, 2024, at the registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380055, which commenced at 3:00 P.M. and concluded at 9:40 P.M., inter alia has considered and approved Audited Financial Results of the Company for the Half Year and Year ended on 31st March, 2024 along with Auditors report.Dipna Pharmachem Ltd - 543594 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, 12Th June, 2024
Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2024 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, 12th June, 2024 at 3:00 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India - 380 055, inter-alia, to consider and approve the Audited Financial Results of the Company for the Half Year and Year ended on 31st March, 2024 along with Auditor Report.Dipna Pharmachem Ltd - 543594 - Board Meeting Outcome for Outcome Of Board Meeting Held On 6Th May, 2024
Outcome of Board Meeting held on 6th May, 2024Dipna Pharmachem Ltd - 543594 - Board Meeting Intimation for Re-Schedule Of Board Meeting Held Today I.E. 2Nd May, 2024
Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2024 ,inter alia, to consider and approve Pursuant to the second proviso to Regulation 30(6) of the SEBI (LODR) Regulations, 2015, we hereby inform you the Board of Directors of the Company meeting held today i.e. Thursday, 2nd May, 2024 which commenced at 2:00 P.M., and Concluded at 7:30 P.M., at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, has decided to Re-schedule the meeting to be held on 6th May, 2024 for discuss and consider, inter-alia: ? The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. ? The proposal of sub-division of equity shares of the Company. ? The proposal of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis. Note that meeting is reschedule due to requirement of expert advice.Dipna Pharmachem Ltd - 543594 - Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Statement on Deviation or Variation of funds under Regulation 32 of SEBI (LODR) Regulations, 2015.Dipna Pharmachem Ltd - 543594 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024
Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015.Dipna Pharmachem Ltd - 543594 - Submission Of Certificate Under Regulation 40(9) Read With Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024
Submission of Certificate under Regulation 40(9) read with Regulation 40(10) of SEBI (LODR) Regulations, 2015 for the financial year ended on 31st March, 2024.Dipna Pharmachem Ltd - 543594 - Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 26Th April, 2024 To 2Nd May, 2024
Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company which was supposed to be held on Friday, 26th April, 2024 at 2:00 P.M., is now rescheduled to Thursday, 2nd May, 2024 at 2:00 P.M. at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, to discuss and consider, inter-alia: 1. The proposal of issue of Bonus equity shares to the existing equity shareholders of the Company. 2. The proposal of sub-division of equity shares of the Company. 3. The proposal of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis.Dipna Pharmachem Ltd - 543594 - Update on board meeting
Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015, we hereby inform you that in continuation to the intimation submitted on 8th April, 2023 vide Acknowledgement No.: 7079374 to the Exchange, in the meeting of the Board of Directors of the Company which will be held on Friday, 26th April, 2024 at 2:00 P.M., at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India, 380055, the agenda of raising of funds by way of issue of Equity shares and/ or Warrants on preferential basis shall also be placed for discussion and consideration. Further, this intimation is submitted to the reference of Board meeting held will be held on 26th April, 2024 and the link of the earlier announcement is https://www.bseindia.com/xmldata/ corpfiling/AttachHis/f00282ab-9375-4f0b-bd73 2463d3c5554b.pdfThe latest market price of Dipna Pharmachem Ltd. on NSE was Rs. 8.15 as of today.
The opening share price of Dipna Pharmachem Ltd. was Rs. 8.20 as of today.
The 52-week high share price of Dipna Pharmachem Ltd. was Rs. 29.40.
The 52 week low share price of Dipna Pharmachem Ltd. was Rs. 7.50.
Dipna Pharmachem Ltd. has a market cap of Rs. 19.60 crore as of today. Please refer to the Fundamentals section for further details.
The PE ratio of Dipna Pharmachem Ltd. is 0.00. Please refer to the Fundamentals section for further details.
The operating revenue for Dipna Pharmachem Ltd. in the last FY was Rs. 0.00 crore. Please refer to the Financials section for further details.
The Net Profit for Dipna Pharmachem Ltd. in the last FY was Rs. 0.00 crore. Please refer to the Financials section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Dipna Pharmachem Ltd..